Resources
Publications
May 1, 2021
Methyl 2-Amino-4-[1-(tert-butoxycarbonyl)azetidin-3-yl]-1,3-selenazole-5-carboxylate
August 17, 2020
PEARL-seq: A Photoaffinity Platform for the Analysis of Small Molecule-RNA Interactions
August 16, 2019
Facile synthesis of novel amino acid-like building blocks by N-alkylation of heterocyclic carboxylates with N-Boc-3-iodoazetidine
June 7, 2018
L-Proline and related chiral heterocyclic amino acids as scaffolds for the synthesis of functionalized 2-amino-1,3-selenazole-5-carboxylates
FAQ
Do you have questions about our technologies, services, or collaborations? Visit our FAQ page to find answers to the most common inquiries, including:
- How our technologies work
- Partnership opportunities
- Insights into our services
Explore the FAQ section to get detailed information and learn more about what we do.
News
October 7, 2025
Vipergen launches new DEL series with Lib100 and updates Series 50 to Lib058
November 11, 2024
SARomics Biostructures and Vipergen collaborate to offer enhanced drug discovery services
April 19, 2024
Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery services.
June 15, 2022
Vipergen and LEO Pharma Partner for DNA Encoded Library (DEL)-Based Drug Discovery for Dermatology Indications
April 4, 2022
Vipergen Establishes DNA Encoded Library (DEL)-Based Drug Discovery Partnership with Theseus Pharmaceuticals Focused on Targeted Cancer Therapies
December 21, 2021
Vipergen Establishes Research Partnership with Bayer to Discover Novel Compounds for Pharmaceuticals and More Sustainable Crop Protection Solutions
Articles
February 25, 2026
Structural Proteins as Drug Targets: In-Cell DEL Screening for Oncology Programs
February 3, 2026
Ion Channels as Drug Targets: Modern Strategies for Ligand Discovery, Screening, and Early Hit Identification
January 21, 2026
Receptors as Drug Targets: Intracellular Ligand Discovery Using DNA-Encoded Libraries
November 14, 2025
Transcription Factor Inhibitors: From “Undruggable” to Drug Discovery Reality
Conferences
| Event | Location | Date | |
|---|---|---|---|
CMC FALL SYMPOSIUM | Copenhagen, DK | November 5, 2026 | Read more |
37th BMCS Spring Symposium on Medicinal Chemistry | Hatfield, UK | April 23, 2026 | Read more |
American Association for Cancer Research Annual Meeting | San Diego, CA, US | April 17-22, 2026 | Read more |
Proximity Based Biology and Therapeutics: Targeted Protein Degradation and Beyond | Banff, AB, Canada | February 23-26, 2026 | Read more |
12th Novalix Conference – Biophysics in Drug Discovery | San Diego, CA, USA | February 17-19, 2026 | Read more |
SLAS2026 International Conference & Exhibition | Boston, MA, US | February 7-11, 2026 | Read more |
5th Alpine Winther Conference on Medicinal and Synthetic Chemistry | St. Anton, Austria | January 25-29, 2026 | Read more |
Drug Discovery Chemistry Europe | Barcelona, Spain | November 11-13, 2025 | Read more |
ELRIG: Drug Discovery 2025 | Liverpool, UK | October 11-13, 2025 | Read more |
Discovery on Target | Boston, US | September 22-25, 2025 | Read more |
Posters
Generation of 3D Diverse DNA-Encoded Libraries
Generation of 3D Diverse DNA-Encoded Libraries
DELs in Cells – Direct Screening for Molecular Glue
DELs in Cells – Direct Screening for Molecular Glue
DELs in Cells – Direct Screening for PPI Inhibitors
DELs in Cells – Direct Screening for PPI Inhibitors
Generation of High-quality and Diverse DNA-Encoded Libraries
Generation of High-quality and Diverse DNA-Encoded Libraries
Multiplex Screening of DNA-Encoded Small Molecule Libraries inside a Living Cell
Multiplex Screening of DNA-Encoded Small Molecule Libraries inside a Living Cell
DELs in Cells: Turn-Around-Time Optimized